The ARVS are always endeavoring to improve the benefits we offer to members, and to assist other industry bodies. After consultations with BHA, Racecourses and Veterinary Surgeons working on Racecourses and Point to Point courses, we have decided to build a database of Veterinary Surgeons qualified by CMS attendance and willing to work, or already working, on Racecourses or at Point to Points.
British Horseracing Authority (BHA) has announced that it has completed the initial stage of its enquiry into the positive results for morphine recently detected in a number of post-race samples.
It was announced by the British Horseracing Authority last week that a number of post-race samples obtained after recent race meetings had tested for morphine. The morphine is thought to have come from feed contamination, with supplier Dodson and Horell stating that one of their suppliers had informed them ‘of a possible component contamination.’ Continue reading
The British Horseracing Authority (BHA) has been notified by LGC analytical laboratory (formerly HFL Sport Science) that a number of post-race samples obtained from recent race meetings have been found, upon analysis of the ‘A’ samples, to have present in them morphine, a prohibited substance on raceday under the Rules. BHA have received certificates of analysis to this effect. Continue reading
The British Horseracing Authority (BHA) today announced that Dr Jerry Hill has been appointed to the role of Chief Medical Adviser (CMA) for BHA. Continue reading
The British Horseracing Authority (BHA) has today published details of British Racing’s enhanced, zero-tolerance policy towards the use of anabolic steroids.
Britain’s leading equine welfare organisations and charities are gathering together under one roof at the Aintree Grand National meeting to raise awareness of welfare issues in the wider equine population. Continue reading
ARVS day meeting on 3rd June 2014 at Tattersalls, Newmarket
Medication in Racing: “What’s legal, what isn’t; what works, what doesn’t”.
The summer meeting this year focuses on therapeutics and aims to update clinicians on the benefits (and potential perils) of medicating horses that race or compete.
The subject areas will be diverse, ranging from legal and regulatory aspects to common clinical problems that we see in racehorses.
To download a Registration form please go to the Events page.